AKT1 and osteosarcoma: We therefore proposed a hypothesis that circNRIP1 delivered by bone marrow mesenchymal stem cell–derived EVs (BMSC-EVs) may augment osteosarcoma development involving the interaction with miR-532-3p, AKT3, and PI3K/AKT.